By Andrea Anderson

SAN DIEGO (GenomeWeb News) – While genome-wide association studies have long been considered an avenue for improving diagnostics, prognostics, and treatment, their most immediate application appears to be for improving drug safety and decreasing adverse events, according to Lon Cardon, senior vice president of GlaxoSmithKline's genetics program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.